Company Overview and News

 
Zurich is Australia’s biggest life insurer with US$2bil ANZ purchase

2017-12-12 thestar.com.my
SYDNEY: Zurich Insurance has agreed to buy Australia and New Zealand Banking Group’s life insurance arm for A$2.85bil (US$2.1bil), its biggest foray into Australia and its third in the last two years.

 
Zurich Insurance to buy ANZ's life insurance businesses for $2.85b

2017-12-12 theage.com.au
ANZ Bank is selling its life insurance business to Swiss giant Zurich for $2.85 billion, joining the exodus by Australian banks from the wealth management sector.

 
Zurich Insurance to buy ANZ's life insurance businesses for $2.85b

2017-12-12 smh.com.au
ANZ Bank is selling its life insurance business to Swiss giant Zurich for $2.85 billion, joining the exodus by Australian banks from the wealth management sector.

 
Zurich becomes Australia's biggest life insurer with $2.1 billion ANZ purchase

2017-12-12 in.reuters
ZURICH/SYDNEY (Reuters) - Zurich Insurance has agreed to buy Australia and New Zealand Banking Group’s life insurance arm for A$2.85 billion ($2.1 billion), its biggest foray into Australia and its third in the last two years.

 
Zurich Insurance to buy ANZ's life insurance businesses for US$2.14 billion - Channel NewsAsia

2017-12-11 channelnewsasia
Zurich Insurance has agreed to buy ANZ's OnePath Life insurance businesses for 2.85 billion Australian dollars (US$2.14 billion), the latest and largest foray by the Swiss company into the Australian market.

 
Year End Results Presentation-Replacement

2017-03-24 londonstockexchange
The following replaces the announcement released on the 24 March 2017 at 12.33 (RNS Nr: 4854A). Please note amended number in the Financing activities paragraph on page 13 of the attached presentation.

 
Year End Results Presentation

2017-03-24 londonstockexchange
Travelex, the world's leading foreign exchange specialist, announces continued growth for the year ended 31 December 2016

 
Markets Live: Miners on a roll

2017-02-12 theage.com.au
The big miners are set to lead the market higher, after iron ore surged on Friday and Wall St hit new all-time peaks as global sentiment remains upbeat, while the local earnings season steps up two notches.

 
Markets Live: Miners on a roll

2017-02-12 smh.com.au
The big miners are set to lead the market higher, after iron ore surged on Friday and Wall St hit new all-time peaks as global sentiment remains upbeat, while the local earnings season steps up two notches.

 
Zurich Insurance to buy Cover-More for US$551mil

2016-12-13 thestar.com.my
SYDNEY: Switzerland’s Zurich Insurance Group has agreed to buy Australia’s biggest travel insurance provider, Cover-More Group, for A$741mil (US$551mil), stepping up its investment in the Australian market.

 
Zurich Insurance agrees to buy Australia's Cover-More for US$551 mil

2016-12-12 theedgemarkets
SYDNEY (Dec 12): Switzerland's Zurich Insurance Group has agreed to buy Australia's biggest travel insurance provider, Cover-More Group, for A$741 million (US$551 million), stepping up its investment in the Australian market.

 
RPT-Overseas casinos clean up despite China's cash curbs

2016-12-12 reuters
SAIPAN Dec 11 For evidence of the odds stacked against China's battle to stop the flight of cash battering its currency and draining its reserves, look no further than the tiny Pacific island of Saipan, which has hit the jackpot with a flood of Chinese money at its new casino.

 
BRIEF-Hearmeout files for new U.S. patent application and secures deal with Ford

2016-12-12 feeds.reuters
* Co has secured a distribution agreement with Ford motors to include hearmeout app within Ford's sync applink technology Source text for Eikon: Further company coverage:

 
REFILE-Australia's Cover-More agrees to $551 mln bid from Zurich Insurance

2016-12-11 reuters
SYDNEY, Dec 12 Australian travel insurance provider Cover-More Group on Monday said it had agreed to a A$741 million ($551.16 million) takeover offer from Switzerland's Zurich Insurance Group.

 
BRIEF-GI Dynamics seeks trading halt of its ASX-listed shares

2016-12-11 feeds.reuters
* Co has secured a distribution agreement with Ford motors to include hearmeout app within Ford's sync applink technology Source text for Eikon: Further company coverage:

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...